Results 171 to 180 of about 44,698 (301)

Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies

open access: green, 2020
Brian H. Santich   +5 more
openalex   +2 more sources

Figure S7 from A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer

open access: gold, 2023
Akira Iizuka   +11 more
openalex   +1 more source

Gain‐of‐function enhancers optimize CAR‐NK cell‐based anti‐cancer immunotherapy

open access: yesImmunology &Cell Biology, Volume 104, Issue 5, Page 494-498, May‐June 2026.
Schematic overview of the two‐stage screening approach used to identify NK cell fitness genes. (A) CRISPRa mechanism, showing dCas9‐VP64‐mediated upregulation of target genes. (B) Whole‐genome CRISPRa screening in HER2‐CAR‐NK92 cells transduced with a CRISPR sgRNA library and transferred into mice bearing HT29 tumours, followed by tumour collection and
Emma Wong   +1 more
wiley   +1 more source

Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo [PDF]

open access: hybrid, 2007
Ming Shi   +9 more
openalex   +1 more source

Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa. [PDF]

open access: yesNat Commun
Kinoshita M   +8 more
europepmc   +1 more source

Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice. [PDF]

open access: yesInt J Mol Sci
Klein SG   +12 more
europepmc   +1 more source

Comparative analysis of anti-MICA scFv affinities: Insights from three label-free biophysical methods and biological validation. [PDF]

open access: yesBiotechnol Rep (Amst)
Toledo-Stuardo K   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy